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Background: Axonopathy is critical in the early pathogenesis of neurodegenerative diseases, including Parkinson’s
disease (PD) and dementia with Lewy bodies (DLB). Axonal swellings such as globules and spheroids are a distinct
feature of axonopathy and our recent study showed that transgenic (tg) mice expressing DLB-linked P123H
β-synuclein (P123H βS) were characterized by P123H βS-immunoreactive axonal swellings (P123H βS-globules).
Therefore, the objectives of this study were to evaluate α-synuclein (αS)-immunoreactive axonal swellings
(αS-globules) in the brains of tg mice expressing human wild-type αS and to compare them with the globules in
P123H βS tg mice.
Results: In αS tg mice, αS-globules were formed in an age-dependent manner in various brain regions, including
the thalamus and basal ganglia. These globules were composed of autophagosome-like membranous structures
and were reminiscent of P123H βS-globules in P123H βS tg mice. In the αS-globules, frequent clustering and
deformation of mitochondria were observed. These changes were associated with oxidative stress, based on
staining of nitrated αS and 4-hydroxy-2-nonenal (4-HNE). In accord with the absence of mitochondria in the P123H
βS-globules, staining of nitrated αS and 4-HNE in these globules was weaker than that for αS-globules. Leucine-rich
repeat kinase 2 (LRRK2), the PARK8 of familial PD, was detected exclusively in αS-globules, suggesting a specific role
of this molecule in these globules.
Conclusions: Lysosomal pathology was similarly observed for both αS- and P123H βS-globules, while oxidative
stress was associated with the αS-globules, and to a lesser extent with the P123H βS-globules. Other pathologies,
such as mitochondrial alteration and LRRK2 accumulation, were exclusively detected for αS-globules. Collectively,
both αS- and P123H βS-globules were formed through similar but distinct pathogenic mechanisms. Our findings
suggest that synuclein family members might contribute to diverse axonal pathologies.
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α-Synucleinopathies such as Parkinson's disease (PD)
and dementia with Lewy bodies (DLB) are leading causes
of movement disorders and dementia in aging popula-
tions [1,2]. α-Synucleinopathies are characterized by the
presence of Lewy bodies and Lewy neurites, which are
filled with aggregates of α-synuclein (αS), an abundant
nerve terminal protein with unknown functions. It is
well established that αS has a central role in the patho-
genesis of these diseases, but little is known about the
onset and progression of the degenerative process.
Recently, evidence has accumulated to indicate that an
axonal pathology caused by αS may play a critical role in
the early pathogenesis of α-synucleinopathies. This is sup-
ported by the widespread axonal pathology observed from
the earliest stages of these disorders, suggesting that
axonal function may be impaired in the early pathogenesis
[3]. In this context, the appearance of αS-positive Lewy
neurites has been shown to precede that of Lewy bodies
in brains and cardiac sympathetic neurons. These results
suggest that degeneration begins in the distal axon and
proceeds towards the cell body in α-synucleinopathies
[4,5]. Thus, elucidation of the mechanisms of axonal path-
ology is important to gain a better understanding of the
early pathogenesis of α-synucleinopathies and to establish
effective therapeutic agents.
Axonal pathologies such as axonal deposits of αS and
axonal swellings have been shown in various lines of
transgenic (tg) mice expressing either wild-type αS or βS
with PD-linked missense mutations [6-9], but have not
been characterized extensively. Furthermore, not only
αS, but also two αS-related molecules, β-synuclein (βS)
and γ-synuclein (γS), are associated with neuritic path-
ology [10,11], such as that in dystrophic neurites and
spheroid structures, in the brain in synucleinopathies.
Thus, it is unclear how the synuclein family of peptides
is involved in the axonal pathogenesis. Based on our
findings for formation of axonal swellings in tg mice
expressing DLB-linked P123H βS [12], we wondered if
these swellings might be a useful model to investigate
the axonal pathology caused by each synuclein protein.
In this context, the objective of the present study was to
characterize axonal swellings of tg mice expressing
human αS and to compare them with those found in
P123HβS tg mice. The results suggest that axonal swel-
lings found in these two types of mice may be formed by
similar but distinct mechanisms.
Results
Age-dependent formation of αS-accumulated axonal
swellings (αS-globules) in brains of αS tg mice
To evaluate αS-induced axonal pathologies in the brains
of αS tg mice, various histological analyses were carried
out. Hematoxylin and eosin staining showed no apparentchanges (Figure 1a), but immunohistochemistry of
brain sections of αS tg mice, but not of their wild
type littermates, exhibited formation of strongly αS-
immunoreactive axonal swellings in various areas,
including the basal ganglia, thalamus, midbrain and
olfactory bulb, but not in the cortex and cerebellum
(Figure 1, Additional file 1: Figure S1a). These swellings
formed in an age-dependent manner, with the highest
number occurring in old stage (Figure 1b). The αS-
immunoreactive swellings were occasionally immunopo-
sitive for heavy chain of kinesin as an axonal marker, but
were not stained by eosin or anti-neurofilament-L anti-
body (Figure 1c), suggesting that they were a type of
axonal swellings. In addition, the long-axis diameter
of αS-immunoreactive swellings was 6.55 ± 2.56 μm
(mean ± S.D., n = 30 globules). Because the diameters of
the swellings were less than 20 μm, they were categor-
ized as “globules” (small spheroids). The swellings were
not stained by Thioflavin T or Thiazine Red (data not
shown) [13,14], suggesting that fibrillation of accumu-
lated αS was not required for formation of αS-globules
in brains of αS tg mice.
The αS-globules were immunopositive for several
GABAergic markers, including anti-γ-aminobutyric
acid (GABA) and anti-glutamic acid decarboxylase
(Additional file 2: Figure S2a), and negative for other neur-
onal markers such as vesicular glutamate transporter-1
or −2, dopamine transporter, vesicular acetylcholine
transporter and serotonin (data not shown). These
results suggest that the αS-globules might be derived from
GABAergic neurons. Furthermore, the αS-globules were
highly immunopositive for calbindin D-28 k, but were par-
tially positive for calretinin, and only occasionally positive
for parvalbumin (Additional file 2: Figure S2b), suggesting
that the globules might be derived from several types of
GABAergic neurons. The mechanism through which
globules caused by αS are preferentially formed in
GABAergic neurons is unclear. However, our results
are consistent with previous studies showing that both
dopaminergic neurons and other neuronal types, includ-
ing large cholinergic interneurons and medium-sized
GABAergic projection neurons, are involved in the neur-
itic pathology in the neostriatum of the PD brain.
Lysosomal pathology of αS-globules in brains of αS tg mice
To investigate the ultrastructure of αS-globules in
brains of αS tg mice, immunoelectron microscopy was
performed (Figure 2). Similarly to the globules in P123H
βS tg mice [15], the αS-globules in αS tg mice were
characterized by membranous elements including au-
tophagosome-like structures with double membranes
(Figure 2a-e), multivesicular bodies (Figure 2b, e) and
multilayered membranes (Figure 2d). These results sug-




















Figure 1 Age-dependent formation of αS-immunopositive axonal swellings (αS-globules) in brains of αS tg mice. (a) Hematoxylin
and eosin staining (upper two panels) showed no apparent changes in brains of αS tg mice (right) and non-tg littermates (left).
Immunohistochemistry of αS (lower two panels) showed formation of αS-globules (arrows) in αS tg mice (right), but not in wild type littermates
(left). Representative images for the thalamus are shown. Scale bar = 20 μm. (b) Age-dependent formation of αS-globules in the αS tg brain
detected by anti-αS antibody. The numbers of globules with diameters >4 μm were unbiasedly counted in the striatum of αS tg brains at three
ages: young (n = 5, 3–4 mo), adult (n = 3, 10–13 mo), and old (n = 3, 21–25 mo). (c) Double immunofluorescence was performed using αS as a
globule identification. Kinesin heavy chain (kinesin hc) was positive (upper three panels) and neurofilament-light (NF-L) was negative (lower three
panels). Representative images are shown for the pontine nuclei (upper) and striatum (lower). Scale bar = 5 μm.
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nous structures, comprised of alternating dense and light
band forms with a periodicity of 5.8-6.1 nm units and an
electron-dense line thickness of 3.3-3.6 nm units, were
present in the αS-globules (Figure 2i, j). Moreover, the
tubular inclusions (13- to 18-nm diameter) existed in the
αS-globules (Figure 2f, h). These structures were reminis-
cent of the fingerprint profile [16] and curvilinear body
[17] that are frequently associated with lysosomal storage
diseases such as neuronal ceroid-lipofuscinosis and gang-
liosidosis. Neither such membranous structures nor Lewy
body-like filamentous structures were observed in the
somata of αS-expressing neurons.
To characterize the lysosomal pathology in the αS-
globules in more detail, an immunofluorescence study was
carried out. The globules were immunopositive not onlyfor major gangliosides (GD1a and GM1) but also for
some minor gangliosides (GD3, GM2 and GM3) [18,19]
(Additional file 3: Figure S3). Based on our previous reports
regarding the protective effects of gangliosides on lysosomal
pathology in neuroblastoma cells expressing P123H ßS, we
speculate that gangliosides might be protective against for-
mation of globules. Finally, the activities of cathepsins B
and -D were significantly decreased in αS tg mice com-
pared with non-tg littermates (The mean activity of ca-
thepsin B was 69.8 ± 14.2% and that of cathepsin D was
86.6 ± 10.6%) (Additional file 1: Figure S1, Additional file 4:
Additional Methods). These results suggest, but do not
prove, that autophagosome-like membranes might accumu-
late due to decreased clearance by lysosomes. Essentially
similar results were previously observed in brains of P123H
ßS tg mice [15].






Figure 2 Ultrastructure of αS-globules in brains of αS tg mice. Immunoelectron microscopic analysis was performed using anti-αS.
αS-immunopositive globules (a) were characterized by lysosomal pathologies such as an αS-immunopositive multivesicular body (b: arrow),
autophagic vacuoles (c), myelinosome (d: arrow), a myelinoid membrane (e: arrow), and a light multivesicular body (e: arrow head). Formation of
a fingerprint profile ( j) adjacent to a lipid droplet ( j: L) and curvilinear bodies (f, h) are reminiscent of lysosome storage disease. Accumulation of
mitochondria was also occasionally observed (f, i; blue). Some mitochondria were swollen and deformed (g). The globules are representatives of
those in the thalamus (a-h) and striatum (i, j). The boxed area in panels with lower magnifications (a, c, f, and i) were enlarged in b, and j or in
two figures (d, e, g, h). Scale bar = 2 μm for c, f, i; 200 nm for b, d, e, g, h, j.
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in αS-globules in brains of αS tg mice
Besides a lysosomal pathology, immunoelectron micros-
copy showed accumulation of mitochondria in αS-
globules in brains of αS tg mice. Some αS-globules
displayed clustering of mitochondria (Figure 2f, i), while
others had swollen mitochondria in the peripheral regions
of the globules (Figure 2g). Consistent with the deform-
ation of the mitochondria, there was a clear decrease in
their osmophility (Figure 2g), indicating increased pH in
the intermembrane space of mitochondria. However, more
severe mitochondrial pathologies, such as distorted and
vacuolated mitochondria, were not observed.
To characterize the mitochondrial pathology in the αS-
globules, an immunofluorescence study was conducted.
The results showed that αS-globules were immunopositive
for various mitochondria markers, including voltage-dependent anion channel isoform 1 (VDAC1), cyto-
chrome C and the stress protein heat shock protein 60
(HSP 60) (Figure 3). All VDAC1 immunohistochemical
images in αS-globules showed a diffuse pattern (67% in
the thalamus, n = 12). This pattern of VDAC1 staining
suggested possible damage of mitochondrial outer mem-
brane [20]. However, it is unlikely that apoptosis was
involved since cytochrome C and HSP 60 staining was still
localized in the swollen mitochondria. The absence of
COX IV, a cytochrome C oxidase subunit in the mito-
chondrial inner membrane, in the αS-globules is consist-
ent with a report showing that genes derived from
mitochondrial DNA, including COX IV, are deleted in
many cases of sporadic PD [21].
Abnormal accumulation of mitochondria in αS-globules
might stimulate oxidative stress. This possibility was









Figure 3 Localization of mitochondrial marker proteins in αS-globules and P123H ßS-globules. Because P123H βS-immunopositive
globules in brains of P123H βS tg mice were immunopositive for αS (~100%), double immunofluorescence analyses of αS tg mice (twelve
left panels) and P123H ßS tg mice (nine right panels) were performed using αS as a globule identification. In αS tg mice, cytochrome C
(upper panels) and HSP60 (lowest panels) showed punctate patterns, while VDAC1 (third panels) was located diffusely. In contrast, COX IV
(second panels) was not detected. In P123H βS tg mice, cytochrome C (upper panels), COX IV (middle panels) and VDAC1 (lower panels)
were all immunonegative. Representative images are shown for the thalamus in αS tg mice and the basal ganglia in P123H βS tg mice.
Scale bar = 5 μm.
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logical lipid peroxidation (Figure 4) [22,23]. In support
of this hypothesis, considerable amounts of the αS-
globules were immunostained with anti-nitrated-αS
antibody (~61% in the basal ganglia, n = 59), suggest-
ing that nitration was upregulated (Figure 4). Similarly,
the αS-globules had the immunoreactivity for anti-4-
HNE antibody (~43% in the basal ganglia, n = 54),
confirmed that the oxidative stress was increased in
the αS-globules (Figure 4). Phosphorylation of αS was
evaluated as another possible posttranslational modifi-
cation, since Lewy bodies in human brains are consist-
ently immunopositive with anti-phospho-αS antibody
[22,23]. In αS tg mice, many but not all of the αS-
globules were stained with anti-phospho-αS antibody
(~62% in the basal ganglia, n = 63), indicating that
phosphorylation of αS may not be critical for globule
formation.Oxidative stress without mitochondria in P123H
ßS-globules in brains of P123H ßS tg mice
In contrast to the αS-globules, our previous ultrastruc-
tural study showed that mitochondria were rarely
observed in P123H ßS-globules in brains of P123H ßS tg
mice [15]. Similarly to the results in αS tg mice, P123H
ßS tg mice had P123H ßS-immunopositive swellings
(P123H ßS-globules) derived from GABAergic projec-
tion neurons which were immunoreactive for calbindin
D-28 k, but were negative for both calretinin and parval-
bumin [15]. We observed that the long-axis diameter of
P123H ßS-globules (5.70 ± 1.15 μm, mean ± S.D., n =
30 globules) was comparable to that of αS-globules
(6.55 ± 2.56 μm. p = 0.10, Student's t-test). Staining for
VDAC1, cytochrome C and COX IV was negative in
P123H ßS-globules in brains of P123H ßS tg mice
(Figure 3). In accord with the absence of mitochondria,

















Figure 4 Characterization of αS modification and oxidative stress for αS-globules and P123H ßS-globules. (a) Double
immunofluorescence analyses of αS tg mice (nine left panels) and P123H ßS tg mice (nine right panels) were performed using αS as a
globule identification. Phosphorylation of αS, nitration of αS, and 4-HNE staining occurred to different extents in the two types of mice.
Representative images are shown for the basal ganglia and thalamus in αS tg mice and for the basal ganglia in P123H βS tg mice.
Scale bar = 5 μm. (b) Quantification of data for phosphorylation of αS, nitration of αS, and 4-HNE in the basal ganglia. (n = 3-4, over 18 mo).
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that in αS tg mice (~27% in the basal ganglia, n = 55)
(Figure 4). In a similar fashion, nitration of endogenous
mouse αS in P123H ßS-globules was negligible (~13%
in the basal ganglia, n = 54) (Figure 4), while phos-
phorylation of endogenous mouse αS in P123H ßS-
globules was similar to that in αS-globules in the basalganglia of αS tg mice (~42% in the basal ganglia, n = 55)
(Figure 4).
The mechanism through which P123H βS stimulates
formation of globules in the absence of mitochondria in
axonal degeneration is unclear. We hypothesized that
cholesterol might play a role in the pathogenesis, based
on the results of immunoelectron microscopy for P123H
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proximately half of the globules had accumulation of
lipids droplets (Figure 5a). As we expected, cholesterol
detection by Schultz staining was highly positive in glo-
bules in brains of P123H ßS tg mice (Figure 5b). In con-
trast, no staining of cholesterol was observed in globules
in brains of αS tg mice.
Analysis of familial PD-risk factors in globule formation
Since many familial PD risk factors [24,25] have been
implicated in disorders of subcellular organelles such as
lysosomes and mitochondria, we examined whether any
of these factors were involved in globule formation in αS
tg mice or P123H ßS tg mice. Notably, an immunofluor-
escence study showed frequent detection of leucine-rich
repeat kinase 2 (LRRK2) (PARK8) in αS-globules (~79%
in the thalamus, n = 28) (Figure 6a). The staining exhib-
ited a small granular dot pattern, suggesting that LRRK2
might be associated with the membranous structures.
The specificity of staining was confirmed by pre-
absorption of the antibody with the immunogen pep-
tides. In contrast, immunoreactivity of LRRK2 was not
observed for P123H ßS-globules in the basal ganglia of
P123H ßS tg mice (Figure 6b). It is intriguing if absence
of LRRK2 in P123H ßS globule might reflect that LRRK2
strictly differentiates human αS from mouse αS and
human P123H ßS. Alternative possibility to explain the
differential expression of LRRK2 between the αS globule
and P123H ßS globule is that LRRK2 might associate
with some specific molecules which are expressed only
in the αS globule. In this regard, rab5b could be such a
candidate since a recent study has well characterized this
molecule as a binding partner of LRRK2 [26]. Our im-
munofluorescence study showed that LRRK2 associates
with an endosome molecule Rab5B in axon terminals(a) (
Figure 5 Positive staining of cholesterol in P123H βS tg mice. (a) An i
basal ganglia of P123H βS tg mice showed many lipid droplets. Scale bar =
tg mice was performed by Schultz staining. The arrowhead shows choleste
other lipids (brown). Scale bar = 10 μm.with a normal range of size, but Rab5B was not detected
in the αS-globules (Figure 6c). This result suggests a
possibility that LRRK2 have lost the ability to interact
with Rab5B, contributing to endosomal deficits during
globule formation. Furthermore, although previous
reports showed that LRRK2 associated various orga-
nelles, such as mitochondria and lysosome [26,27], we
did not observed interaction of LRRK2 with mitochon-
dria markers in the αS-globules (data not shown).
Furthermore, despite the accumulation of LRRK2 in
the αS-globules, immunoblot analysis [28,29] failed to
detect an apparent difference in LRRK2 bands among
brain extracts derived from αS tg mice, P123H ßS tg
mice, and their wild type littermates (data not shown),
possibly due to the relatively small amount of LRRK2
in the αS-globules compared to total LRRK2 in the
whole brain.
It has been well characterized that Parkin (PARK2)
and PTEN-induced putative kinase 1 (PINK1) (PARK6)
are autosomal recessive factors that are critically
involved in the maintenance of mitochondrial quality,
and that mutations in these genes are causative for mito-
phagy. However, neither Parkin nor PINK1 was immu-
nopositive in αS- and P123H ßS-globules (Figure 6a). In
addition, there was no immunoreactivity for DJ-1
(PARK7) in both types of globules (Figure 6a).
Discussion
Axonal swellings, including globules and spheroids, are
characteristic features of axonopathies observed in a
number of diseases, including ischemia, trauma, neu-
roaxonal dystrophy, neurodegenerative disorders, as well
as in aging. A recent study suggested that dysfunction of
the autophagy-lysosome pathway could be one major
contributor to axonal swellings [30,31]. Failure tob)
mmunoelectron micrograph of αS-immunopositive globules in the
1 μm. (b) Detection of cholesterol in the basal ganglia of P123H βS













Figure 6 (See legend on next page.)
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Figure 6 LRRK2 accumulates in globules in αS tg mice. (a and b) Double immunofluorescence for αS with parkin, PINK1, DJ-1, LRRK2, or
negative control (the immunopeptide-preabsorbed anti-LRRK2 antibody) in αS tg mice (a) and P123H ßS tg mice (b). Note that αS-globules were
immunopositive for LRRK2 (~79%, n = 22), whereas P123H ßS globules were negative for LRRK2. Representative images are shown for the
thalamus (αS) and basal ganglia (P123H ßS). Scale bar = 5 μm for all panels. (c) Triple immunofluorescence for αS, LRRK2 and Rab5B for basal
ganglia in αS tg mice. LRRK2 and Rab5B were colocalized in axon terminal (arrow), but were not colocalized in the αS-globule (arrowhead)
Scale bar = 10 μm for all panels.
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axons and/or nerve terminals or failure to export these
materials by axonal transport has been shown to pro-
duce swollen nerve terminals. Such a mechanism might
be involved in formation of αS- and P123H βS-globules.
In the present study, αS-globules in brains of αS tg mice
were characterized by autophagosome-like membranous
elements and were immunopositive for various minor
gangliosides, which is reminiscent of some types of lyso-
somal storage disease. Consistent with this, lysosomal
activity, as assessed by the activities of cathepsins B and
-D, was significantly decreased in brain extracts of αS tg
mice compared with those from non-tg littermates.
Similar lysosomal dysfunctions were previously observed
for P123H βS-globules in brains of P123H βS tg mice.
Taken together, these results suggest that downregula-
tion of the lysosome degradation pathway may be a
common mechanism leading to globule formation in αS
and P123H βS tg mice.
In contrast to the lysosomal pathology, mitochondria
accumulated specifically in αS-globules. To the best of
our knowledge, only one study has previously described
abnormal mitochondria in the axonal pathology in tg
mice expressing prion promoter-driven αS [32]. In
agreement with this study, immunoelectron microscopy
of αS revealed abnormal accumulation of mitochondria
in αS-globules. Some αS-globules displayed clustering of
mitochondria, while others had swollen mitochondria in
the peripheral regions. Immunoreactivities of mitochon-
drial markers such as VDAC1 and cytochrome C were
also found in αS-globules. These results suggest that
mitochondria clustering might become hyperactive in re-
sponse to lysosomal dysfunction. Consistent with these
findings, αS-globules were associated with oxidative
stress, as assessed by staining of 4-HNE and nitrated αS.
Conversely, no evidence of mitochondria was obtained
in P123H βS-globules, hence oxidative stress (assessed
by 4-HNE staining) was less than that in αS-globules.
The mechanism through which P123H βS causes mild
level of oxidative stress without mitochondria is unclear,
but it is noteworthy that cholesterol staining was posi-
tive in P123H βS-globules but not in αS-globules. Given
that cholesterol and its metabolites are implicated in
oxidative stress in the pathogenesis of neurodegenerative
diseases [33], the increased oxidative stress in P123H
βS-globules could be partly due to accumulation ofcholesterol. A further study is warranted to test this in-
triguing possibility.
LRRK2 was found to be located in αS-globules and
may be actively involved in the axonal pathology. Indeed,
it was previously shown that LRRK2 was crucial for
regulation of neurite formation and length. Knockdown
of LRRK2 led to long, highly branched neuritic pro-
cesses, whereas constructs with increased kinase activity
exhibited short simple processes in neuronal cultures (or
transduced nigrostriatal models) [34]. More recently,
LRRK2R1441G BAC tg mice were shown to have various
characteristic axonal pathologies, including large tyro-
sine hydroxylase-positive spheroid-like structures, dys-
trophic neurites and enlarged axonal endings [35].
Although the mechanisms are still unclear, the specific
accumulation of LRRK2 in αS-globules naturally leads to
the speculation that LRRK2 may cooperate with αS in
the axonal pathology. In support of this possibility,
both αS and LRRK2 have been shown to be com-
monly involved in pathologies such as impairment of
cytoskeleton dynamics and dysregulation of the pro-
tein degradation system. Moreover, it was recently
shown that various neuropathological features of
A53T αS tg mice, such as impaired microtubule dynam-
ics, Golgi disorganization, and decreased proteasomal
activity, were worsened by cross-breeding with LRRK2
tg mice, but ameliorated by genetic ablation of LRRK2
[36]. Further investigation is required to deter-
mine whether αS and LRRK2 cooperate with each other
to produce diverse pathologies, including axonal
degeneration.
Finally, given that P123H βS may represent a rare fa-
milial case of DLB, it is important to consider whether
wild type βS has any role in the formation of axonal glo-
bules in sporadic cases of α-synucleinopathies. In this
context, neurite accumulation of βS has been demon-
strated in various synucleinopathies, including PD, DLB,
and neurodegeneration with brain iron accumulation,
type I. Although wild type βS is neuroprotective, this
molecule might become pathogenic during aging. It is
also possible that wild type βS might become pathogenic
under certain extreme conditions or through the action
of specific environmental factors, leading to stimulation
of globule formation. Thus, it is an intriguing possibility
that the synuclein family of peptides might contribute to
the formation of diverse axonal pathologies.
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The main objectives of this study were to evaluate
αS-globules in the brains of tg mice expressing
human wild-type αS and to compare them with the
P123H βS-globules in P123H βS tg mice. The results
showed lysosomal pathology was similarly observed for
both αS- and P123H βS-globules. Oxidative stress was
associated with the αS-globules, and to a lesser extent
with the P123H βS-globules. Other pathologies, such as
mitochondrial alteration and LRRK2 accumulation,
were exclusively detected for αS-globules. Together,
both αS- and P123H βS-globules were formed through
similar but distinct pathogenic mechanisms, suggesting
that synuclein family members might contribute to di-
verse axonal pathologies.
Methods
All animal procedures were approved and conducted in
accordance with the regulations of the Animal Ethics
Review Committee of Tokyo Metropolitan Institute
of Medical Sciences. Thy1-αS tg mice [37] and Thy1-




The mice were anesthetized by overdose of pentobarbital
and sacrificed by cardiac perfusion using 5 ml of an ice-
cold solution of 250 mM sucrose and 5 mM MgCl2 in
0.02 M phosphate buffer (pH 7.4) (PB), followed by treat-
ment with 4% paraformaldehyde, 15% saturated picric
acid and 0.05% (for single or double-immunohistochem-
istry, and histochemistry), 0.5% (for immunoelectron
microscopic analysis) or 1% (for GABA immunohisto-
chemistry) glutaraldehyde in 0.1 M PB. Serial sections of
20- or 50-μm thickness were then prepared by a vibrating
blade microtome (VT1200S; Leica, Nussloch, Germany).
Tissue sections were put in glass tubes containing 15%
sucrose in 0.1 M PB for 3 h, in 30% sucrose in 0.1 M PB
for 3 h, and kept at −30°C until use [38].
Hematoxylin and eosin staining
Sections were stained with Mayer’s haematoxylin and
0.5% eosin. Sections were imaged using a Carl Zeiss (Jena,
Germany) microscope.
Antisera
All antisera or monoclonal antibodies were purchased
from commercial sources (Table 1).
Immunohistochemistry
The sections were incubated in Tris-buffered saline
(TBS) containing 1% sodium borohydrate for 30 min, in
addition to treatment with TBS containing 1% H2O2 for30 min in the case of diaminobenzidine staining. They
were then incubated with primary antibodies (listed in
Table 1) in PBS containing 1% normal horse serum
and 0.4% Triton X-100 (except that for the lipids detec-
tion) overnight at 4°C, followed by detection with bio-
tinylated secondary antibodies and an avidin-biotin
complex kit (Vector Laboratories, Burlingame, CA) [39].
A positive reaction was detected using diaminobenzidine
tetrahydrochloride (DAB) containing 0.01% hydrogen
peroxide and counterstaining with hematoxylin. For de-
tection with fluorescent dye, the sections were incubated
with primary antibodies, followed by Alexa Fluor-
conjugated secondary antibodies (Invitrogen, Carlsbad,
CA). The sections were observed using a sectioning
fluorescence microscopy system (Apotome; Carl Zeiss,
Jena, Germany).
Immunoelectron microscopy
The sections were incubated in PB containing 1% so-
dium borohydrate for 30 min and in TBS containing 1%
H2O2 for 30 min before incubation with primary anti-
serum against αS in TBS containing 10% normal goat
serum and 2% bovine serum albumin overnight at 4°C.
The sections were then incubated in biotin-conjugated
secondary antiserum followed by treatment with ABC
complex (Vector Laboratories) and staining with nickel-
enhanced DAB. The stained sections were postfixed in
1% OsO4 in 0.1 M PB for 60 min, and then stained with
1% uranyl acetate and dehydrated in graded ethanol.
Sections were flat embedded on silicon-coated glass
slides in Quetol 812 (Nisshin EM, Tokyo, Japan). Immu-
nopositive tissues were serially sectioned at 70-nm thick-
ness with EM UC7 (Leica), followed by final staining
with lead citrate. The labeled αS-globules were photo-
graphed using an H-7650 electron microscope (Hitachi,
Tokyo, Japan) and image files were made from EM films
using a scanner (GT-X970; Epson, Suwa, Japan) [38].
Cholesterol staining
The sections were incubated in 2.5% iron alum solution
for 3 days at room temperature. Sections were onto
slides, followed by draining the solution and drying.
Schultz reagent (mixture of equal parts of glacial acetic
acid and concentrated sulfuric acid) was applied onto
the slide, and then a glass coverslip was mounted [40].
Sections were imaged using an Olympus (Tokyo, Japan)
microscope.
Globule counting
For the caudate and putamen, sagittal sections approxi-
mately 1.3-1.9 lateral to the midline were used. The loca-
tion of the slice and identification of brain regions were
determined by comparison to atlas images, as previously
described [15]. Fluorescent labeled αS-immunopositive
Table 1 Primary and secondary antisera used in this study
Antigen Host Dilution Mono/polyclonal Source
Primary antisera and antibodies
1 α-synuclein mouse 1:500 (for EM) monoclonal BD Biosciences (610787)
1:1000 (for GABA FIHC)
1:2000
2 α-synuclein rabbit 1:50 polyclonal Cell Signaling (#2628)
3 phosphorylated α-synuclein mouse 1:2000 monoclonal WAKO (pSyn#64)
4 nitrated α-synuclein mouse 1:50 monoclonal Santa Cruz Biotechnology
(sc-32279)
5 4-hydroxy-2-nonenal mouse 1:40 monoclonal NOF Corporation (MHN-020P)
6 Calbindin D-28 k rabbit 1:5000 polyclonal Swant (CB38)
7 Parvalbumin mouse 1:2000 monoclonal Merck Millipore (MAB1572)
8 Calretinin rabbit 1:2000 polyclonal Swant (7699/4)
9 Glutamic acid decarboxylase rabbit 1:2000 polyclonal BIOMOL (GC3008)
10 GABA rabbit 1:2000 polyclonal Sigma (A2052)
11 kinesin, heavy chain mouse 1:50 monoclonal Merck Millipore (MAB1614)
12 neurofilament-ilght mouse 1:200 monoclonal Sigma (N5139)
13 GD1a mouse 1:10 monoclonal Seikagaku Corporation (GMR17)
14 GD3 mouse 1:10 monoclonal Seikagaku Corporation (GMR19)
15 GM2 mouse 1:10 monoclonal Seikagaku Corporation (GMB28)
16 GM3 mouse 1:10 monoclonal Seikagaku Corporation (GMR6)
17 VDAC1 rabbit 1:40 polyclonal Protein Tech (10866-1-AP)
18 cytochrome c mouse 1:200 monoclonal BD Biosciences (556432)
19 COX IV rabbit 1:100 monoclonal Cell Signaling (#4850)
20 HSP60 rabbit 1:50 polyclonal Novus (NB100-91819)
21 Parkin rabbit 1:100 polyclonal Merck Millipore (AB9244)
22 PINK1 rabbit 1:50 polyclonal Novus (NB600-973)
23 DJ-1 rabbit 1:50 polyclonal abcam (ab74268)
24 LRRK2 rabbit 1:200 polyclonal Novus (NB300-268)
25 VGAT guinea pig 1:500 polyclonal Synaptic Systems (131004)
26 Rab5B goat 1:50 polyclonal Santa Cruz Biotechnology
(sc-26569)
Fluorescein conjugated probe
1 Alexa 488 conjugated cholera toxin
subunit B
0.5 μg/ml invitrogen (C-34775)
Fluorescein conjugated secondary antisera
1 Alexa 488 conjugated anti-mouse IgG goat 1:200 polyclonal invitrogen (A-11029)
2 Alexa 488 conjugated anti-rabbit IgG goat 1:200 polyclonal invitrogen (A-11034)
3 Alexa 594 conjugated anti-mouse IgG goat 1:200 polyclonal invitrogen (A-11032)
4 Alexa 594 conjugated anti-rabbit IgG goat 1:200 polyclonal invitrogen (A-11037)
5 Alexa 488 conjugated anti-mouse IgM goat 1:100 polyclonal invitrogen (A-21042)
6 Alexa 680 conjugated anti-goat IgG donkey 1:100 polyclonal invitrogen (A-21084)
Biotinylated secondary antisera
1 biotinylated anti-mouse IgG horse 1:200 polyclonal Vector (BA-2000)
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under a fluorescent microscope or from photomicro-
graphs of sections.
Statistical analysis
Data are given as the means ± S.D. Statistical analysis
was performed using SPSS (SPSS Inc. Chicago, IL). T-test
was used for confirmation of significant differences
among WT or P123HβS tg, and αS tg mice, with P < 0.05
considered to indicate a significant difference.
Additional files
Additional file 1: Figure S1. Lysosome and proteasome activities in the
brain extracts of αS tg mice. (a) αS-globules were detected in the
olfactory bulb (arrow), but not in the cerebellum, of old αS tg mice
(24 mo). Scale bar=2 mm (upper panel), 50 μm (lower two panels). (b)
Cathepsin B, -D and proteasome activities were measured (Additional file 4:
Additional Methods). Activities of lysosome (cathepsins B and –D) were
significantly lower (p<0.05) in the olfactory bulb but not in the
cerebellum in αS tg mice compared to the same areas in non-tg
littermates (over 23 mo). In contrast, there were no significant difference
in proteasome activities (Peptidyl-glutamyl peptide-hydrolyzing (PGPH)
enzyme and chymotrypsin) between αS tg mice and non-tg littermates
(mean±S.D.; *p<0.05, n=6 per group).
Additional file 2: Figure S2. αS-globules are derived from GABAergic
neurons. (a) αS-immunopositive globules in the striatum and thalamus of
old αS tg mice (over 18 mo) were consistently immunopositive for GABA
and glutamic acid decarboxylase (GAD), and were weakly
immunopositive for vesicular GABA transporter (VGAT) (arrowhead). Scale
bar=5 μm. (b) Immunoreactivity for calbindin (CB) was consistently
observed. Staining was partially positive for parvalbumin (PV) and rarely
positive for calretinin (CR) in the thalamus. Scale bar=5 μm.
Additional file 3: Figure S3. Immunoreactivities of gangliosides in
αS-globules of αS tg mice. (a) Double immunofluorescence analysis of
αS tg mice was performed using αS as a globule identification.
αS-immunopositive globules in the thalamus of old αS tg mice (25 mo)
were positively stained with various anti-ganglioside antibodies. Scale
bar=5 μm. (b) Quantification of these data.
Additional file 4: Additional Methods. Measurement of lysosome and
proteasome activity.
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